Even though low cost cards might help reduce the stress of large drug fees during the temporary, they don't handle the systemic problems driving up prescription prices inside the U.S. Broader plan variations could deal with the basis results in of rising drug selling prices, like lack of transparency in pricing along with the part of intermediaries